Vascular endothelial growth factor (VEGF) is a major inducer of angiog
enesis and vasculogenesis. Two distinct receptors for VEGF; the tyrosi
ne kinase receptors VEGFR-1 (Flt-1) and VEGFR-2 (Flk-1/KDR), have been
identified. Transfection studies could demonstrate biological activit
ies for the Flk-1/KDR-, but not for the Flt-1-receptor, which led to t
he hypothesis that Flt-1 is a decoy receptor for VEGF. However, Flt-1
is biologically active in non-endothelial cells, namely monocytes, whi
ch exclusively express this receptor. In addition, the Flt-1 ligand pl
acenta growth factor (PlGF), which is unable to bind and activate Flk-
1/KDR, elicits activities in both monocytes and endothelial cells. The
implications of Flt-1 mediated monocyte transmigration through endoth
elial monolayers and induction Of the procoagulant tissue factor on mo
nocytes for the field of vascular medicine ave discussed. (C) 1998, El
sevier Science Inc.